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Objective: An ulcer categorized as Fontaine’s stage IV represents a chronic wound, risk factor 
of arteriosclerosis, and co-morbidities which disturb wound healing. Our objective was to analyze 
wound healing and to assess potential factors affecting the healing process.
Methods: 199 patients were included in this 5-year study. The signiﬁ  cance levels were 
determined by chi-squared and log-rank tests. The calculation of patency rate followed the 
Kaplan-Meier method.
Results: Mean age and co-morbidities did not differ from those in current epidemiological 
studies. Of the patients with ulcer latency of more than 13 weeks (up to one year), 40% required 
vascular surgery. Vascular surgery was not possible for 53 patients and they were treated con-
servatively. The amputation rate in the conservatively treated group was 37%, whereas in the 
revascularizated group it was only 16%. Ulcers in patients with revascularization healed in 92% 
of cases after 24 weeks. In contrast, we found a healing rate of only 40% in the conservatively 
treated group (p   0.001). Revascularization appeared more often in diabetic patients (n = 110; 
p   0.01) and the wound size and number of infections were elevated (p = 0.03). Among those 
treated conservatively, wound healing was decelerated (p = 0.01/0.02; χ² test).
Conclusions: The success of revascularization, presence of diabetes mellitus, and wound 
treatment proved to be prognostic factors for wound healing in arterial ulcers.
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Introduction
The underlying cause of arterial ulceration is arteriosclerosis obliterans resulting 
in tissue ischemia in 90% of cases. The ulcer itself is categorized as stage IV in the 
Fontaine classiﬁ  cation system (Rutherford category 3 and 4). Only a few articles discuss 
the complex treatment of these wounds or show the inﬂ  uence of revascularization, 
wound management, and risk factor assessment. This study aimed to evaluate the 
factors involved in complex wound treatment.
Subjects and methods
Patients
Over a 5-year period (1997–2001), 199 patients with stage IV peripheral arterial 
occlusive disease (PAOD) were studied. Inclusion criteria were length of hospital stay, 
course of therapy, outpatient monitoring, and wound assessment/treatment (inpatient 
and outpatient). Risk factors, co-morbidities, and the different treatment groups were 
also evaluated (Figure 1).Vascular Health and Risk Management 2008:4(3) 684
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Vascular status/vascular surgery therapy
Imaging procedures such as angiography or magnetic 
resonance angiography (in cases with renal insufﬁ  ciency 
or contrast agent allergy) were used to ascertain an objec-
tive status of the vascular system. The decision to perform 
angioplasty/reconstruction was based on the Trans-Atlantic 
Inter-Society Consensus guidelines (Trans Atlantic Inter-
Society Consensus I 2000).
Wound assessment
To characterize the wound we assessed data on latency, 
localization, size, and type of wound. Localization fell into 
three categories: foot and toe, lower leg, foot and lower leg. 
A lattice grid was used to measure the wound size. A wound 
with a spread of less than 5 cm², or with a single extension 
radiating from the wound, was classiﬁ  ed as a “small wound”. 
A “medium-size wound” was 5–10 cm², or with 2–4 toes 
involved. The category of “large wound” included those 
with a spread beyond 10 cm², and those with the involvement 
of the entire forefoot. The depth was categorized using the 
Knighton classiﬁ  cation (Knighton et al 1986). Ulceration was 
deﬁ  ned as tissue damage which could clinically be described 
as necrosis or gangrene.
The diagnosis of neuropathy resulted from the known 
factors (Morbach et al 2004; Lobmann 2005).
Wound treatment
Wounds were treated according to Vollmar’s IRA principle 
(treatment of infection, revascularization and minor ampu-
tation in the necrobiotic wound margin; Vollmar 1996). 
Necrosis (ie, of the toes) was not removed or debrided before 
revascularization. A gangrenous or phlegm-ﬁ  lled status 
required surgical intervention to control wound infection 
(eg, incision, drainage, toe amputation) with accompany-
ing antibiotic treatment and local application of antiseptics 
(Kramer et al 1998; Schmidt et al 2000). The general wound 
treatment followed the revised TIME principles of wound bed 
preparation (Bendow et al 1999; Schultz et al 2003) and did 
not differ from current recommendations (Hopf et al 2006). 
Ulcer healing, and wound borderline amputation that healed 
well, were considered successful outcomes.
Statistical analysis
The chi-squared and log-rank tests were used to establish 
the statistical signiﬁ  cance of the determinant factors. The 
patency rate was calculated according to the Kaplan-Meier 
method. All statistical tests were performed with SPSS 11.0 
for Windows (Chicago, IL, USA).
Results
Patient characteristics
The average age of the 132 men (66%) and 67 women (34%) 
was 65.4 years. Thirty-two percent of the patients were younger 
than 60 years. Diabetic patients were signiﬁ  cantly older than 
nondiabetic patients with PAOD (p = 0.03; χ² test). Nicotine 
abuse was found among 72% of men and among 26% of 
women. Using the Body Mass Index (BMI) calculation we 
found that 90 patients (45%) were overweight (BMI: 25–30) or 
obese (BMI:  31). Arterial hypertension was seen in 77% of 
Figure 1 Risk factors and comorbidities.
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the women and 49% of the men; of these groups 84% and 60% 
were overweight, respectively. There were 110 patients (55%) 
with diabetes mellitus. This patient group had a greater number 
of previous revascularization treatments on the extremities 
(p   0.01; χ² test) than nondiabetic patients. Women more 
often showed the risk factor combination of arterial hyperten-
sion, diabetes mellitus, and obesity (p = 0.02; χ² test). There 
were 46 patients (23%) with chronic renal insufﬁ  ciency (27 
needed dialysis). Of all risk factors, only diabetes mellitus 
showed a correlation with poor wound healing (Figure 1).
Ulcer characteristics and treatment
We found angiopathic ulcers in 89 (45%) patients without 
diabetes mellitus, whereas among the diabetic patients, we 
found angiopathic or angiopathic-neuropathic ulcers in 
110 (55%). Diabetic patients presented signiﬁ  cantly larger 
wounds (p = 0.03; χ² test) and there was a higher occur-
rence of phlegmonous infection (p = 0.03; χ² test). Wound 
localization and necrotic status or gangrene did not differ 
signiﬁ  cantly between the two groups (PAOD patients with/
without diabetes mellitus) (Table 1). After ulcer duration 
of more than 13 weeks, 40% of the patients were presented 
for vascular surgery (Figure 2). Pre- and post-operative 
antibiotic therapy was administered to 67% of the patients 
because of signs of local or systemic infection (germ spec-
trum: 40% Staphylococcus [3% MRSA], 24% Enterococcus, 
20% Enterobacter, 10% Pseudomonas, and 6% other). Local 
antiseptics were applied in 58% of the cases. Sixty-seven 
percent of the ulcers were surgically debrided. If a patient 
did not have the option of revascularization, or had a small 
superﬁ  cial ulcer, a conservative debridement was performed. 
During the hospitalization, 33% received modern occlusion 
bandaging, and in 10% a biological covering of the wound 
(mesh graft, n = 14; plastic ﬂ  ap, n = 5) was applied. In 
37% of the cases minor amputation (toe amputation) was 
performed after revascularization. An inactive dressing was 
placed on the necrotic tissue until a necrobiotic borderline 
had developed.
Vascular situation/treatment
Twenty-three percent of the cases had undergone previous 
vascular surgery on the affected extremity (10% on the 
contralateral extremity). Major amputation was required in 
2% of the ipsilateral (lower leg) and 4% of the contralateral 
(lower leg and upper leg) cases.
Sixty-one percent of the patients had a multilevel occlu-
sive disease; the thigh-lower leg occlusion type was pre-
dominant (Figure 3). The mean ABI (ankle/brachial index) 
improved by 0.37 to 0.90 (excluding 20% of the diabetic 
patients, who could not be analyzed). In 53 patients (27%), 
the lower leg arteries were either partially or completely 
closed up. Whenever vascular re-connection was not pos-
sible, a conservative treatment was performed (prostaglandin 
infusion, acetylsalicylic acid, heparin, and pain treatment). 
The rate of amputation was 37% in this conservatively treated 
group. Vascular surgery was performed on 146 (73%) of the 
patients. A total of 178 surgical interventions was necessary, 
ie, angioplasty and bypass/endarterectomy, endarterectomy 
and bypass, thrombolysis. Because of the relatively small 
number of cases, and the variation in surgical procedures 
and vascular status, the patency rate is not meaningful for 
evaluating the outcome of treatment (Leng et al 2000). A 
saphenous vein bypass, as opposed to a prosthetic bypass, 
was more advantageous in the upper as well as in the lower 
leg (p = 0.01; log-rank test). In the revascularized group the 
amputation rate was only 16% (n = 24).
Outcome
The average hospital stay was 22 days (range: 12–29 days). 
The time delay until the vascular operation was determined 
by the status of the infection and time needed for assessment 
and treatment of the polymorbidities (median: 5 days; range: 
1–10 days). To assess wound treatment we monitored 150 
wounds (117 patients of the revascularized group and 33 
patients of the conservatively treated group). The amputated 
(n = 43) and the patients who died during their ﬁ  rst hospital 
stay (n = 6) were not included in the analysis.
Table 1 Wound characterization (n = 199)
Grading Classiﬁ  cation Frequency Size Frequency Location Frequency
I epidermal/dermal 7% small ( 5 cm2) 37% foot 78%
II subcutaneous 82% medium 
(5–10 cm2)
35% lower leg 19%
III involving fasciae/muscles 9% ( 10 cm2) large 28% combination 3%
IV involving tendons/bones/joints 2%
V undermining cavities/ﬁ  stulae 0Vascular Health and Risk Management 2008:4(3) 686
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During our 5-year follow up, 22 patients (11%) died. 
At the time of discharge, a total of 47% (n = 70) of the 150 
wounds had healed. Within 24 weeks, 92% of ulcers in the 
revascularizated group healed, whereas only 40% in the 
conservatively treated group showed complete wound heal-
ing at this time point (Figure 4).
Diabetic patients, and patients treated conservatively, 
needed an extended healing time (p = 0.01/0.001; χ² test). 
A second hospital stay was necessary for 67 patients and in 
60% the wound treatment was responsible for hospitalization 
(ie, borderline amputation/minor amputation, debridement). 
Major reasons for a third hospital stay (n = 17) were progress 
of arteriosclerosis or bypass complications (Figure 5a–b). In 
78% (of all patients) the leg could be preserved.
Discussion
General epidemiological data for Germany conﬁ  rm that 2.5 
million patients have PAOD, and 800,000 of these have 
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Figure 2 Ulcer latency until presentation for vascular surgery.
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Figure 4 Rate of healing for arterial ulcers.
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clinically signiﬁ  cant symptoms. Of the stage III and IV 
patients, 25% suffer a substantial disease progression dur-
ing the time of treatment. The vascular component is the 
leading reason for 20,000 major amputations per year in 
Germany (Spengel 2001; getABI Study Group 2002; Cetin 
and Baumgartner 2004; Eckstein and Knipfer 2007).
In this study, the risk factors of PAOD are similar to 
those shown in published data (Treiman et al 2000; getABI 
Study Group 2002; Shammas 2007). In diabetic patients we 
found more severe infections, greater wound size, and longer 
healing times. The high prevalence of ischemia, infection, 
and serious co-morbidity in diabetic foot syndrome was 
conﬁ  rmed in the Eurodiale study (Prompers et al 2007).The 
extrinsic and intrinsic factors leading to decreased healing 
capacity in diabetic patients were determined (Lobmann 
2005). PAOD is not an independent condition in diabetic 
patients (Morbach et al 2004; Scherbaum et al 2004). The 
high rate (22%) of younger patients ( 60 years) who 
were developing arterial ulcers highlights the demographic 
changes compared with previous data, and therefore the need 
for new strategies of prevention.
The long latency period until the patient can be seen in a 
specialized center for vascular surgery indicates deﬁ  ciencies in 
outpatient care and underlines the need to apply the established 
guidelines (Bendow et al 1999; Spengel 2001; Hopf et al 
2006). Other possible risk factors were not evident in our study 
(Treiman et al 2000; Marston et al 2006; Ince et al 2007). A 
timely evaluation and treatment can reduce the mortality of this 
disease (11%–30% of patients in 3–5 years in the literature) 
(getABI Study Group 2002; Cetin and Baumgartner 2002).
Whether the lower mortality of the presented group (11%) 
depended on this specialized treatment in a university hospital 
setting, is speculative and was not further analyzed. The cause 
of death of admitted patients was of cardiovascular origin.
According to statistical data, 25% of patients suffer-
ing from PAOD stage IV (Fontaine) receive a medication 
therapy, 25% undergo a primary amputation, and in 50% a 
revascularization is possible (Trans Atlantic Inter-Society 
Consensus I: TASC I, 2000; Spengel 2001).
According to the TASC II, critical limb ischemia within 
one year is associated with an amputation rate of 30% and a 
mortality of 25% (Norgren et al 2007). In our 5-year study, 
the total amputation rate over all patients was 22%. However 
37% of patients were receiving conservative treatment, and 
only 16% of the revascularized patients, were affected.
Marston and colleagues (2006) reported an amputation 
rate of 23% over a 12-month period with similar parameters, 
and in 52% of these patients complete wound healing was 
achieved within one year. As a factor of inﬂ  uence the size 
of the wound was stated; even in our own study, only small 
wounds healed completely in the conservatively treated group. 
The effectiveness of prostanoid therapy is a controversial 
international topic (Spengel 2001; Hopf et al 2006; Minar 
and Schillinger 2007; Norgren et al 2007). The time needed 
for healing of the ulcers under study was less than reported 
in current literature, depending on the criteria for patient 
inclusion. Ince et al reported an 86% rate for 52 weeks (Ince 
et al 2007) and Humphreys and colleagues (2007) reported 
a rate of 87% of complete healing of ulcers without PAOD, 
68% with minimal PAOD, and 53% with severe PAOD. All 
revascularized ulcers healed within 36 weeks. Chung and 
colleagues (2006) reported a healing rate of 75% within 12 
months. Treiman and colleagues (2000) showed comparable 
healing rates of 73% within 24 weeks and a leg conservation 
rate of 86% over 3 years. For all authors the positive outcome 
of revascularization was the key parameter for success. Our 
own study however also shows that an extended primary 
hospital stay for wound treatment, followed by several 
consequent hospital stays for wound care (including minor 
and forefoot amputations, debridement), played an important 
role. Studies on modern treatment of arterial ulcer wounds, 
which include recommendations of a wound covering, are 
not available (Bendow et al 1999; Tautenhahn and Piatek 
2006; Nelson and Bradley 2007). The principle of wound bed 
preparation is none the less valid for all chronic wounds. It 
takes into account the status of the infection, the treatment of 
gangrene before revascularization of the arterial ulcers, as well 
as subsequent wound therapy (Bendow et al 1999; Schmidt 
et al 2000; Schultz et al 2003; Hopf et al 2006; Tautenhahn 
and Piatek 2006).
Revascularization, diabetes mellitus, and wound therapy 
prove to be prognostic factors for the pace and efﬁ  ciency of 
arterial ulcer wound healing. Further factors and other co-
morbidities did not appear to have an inﬂ  uence, even in a 
large patient study group. In agreement with current literature 
the progress of arteriosclerosis, which is also the underlying 
cause of the ulcer, contributes to the higher mortality of this 
group of patients.
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